|
CASP3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.09512440519211E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.76280134723106E-11 |
| Normal-vs-Stage2 |
1.484580E-03 |
| Normal-vs-Stage3 |
2.955900E-03 |
| Normal-vs-Stage4 |
1.639290E-04 |
| Stage1-vs-Stage2 |
3.457000E-01 |
| Stage1-vs-Stage3 |
3.687200E-01 |
| Stage1-vs-Stage4 |
7.079400E-01 |
| Stage2-vs-Stage3 |
8.423200E-01 |
| Stage2-vs-Stage4 |
3.127200E-01 |
| Stage3-vs-Stage4 |
2.687800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.45798953307985E-12 |
| Normal-vs-AfricanAmerican |
5.99840000004015E-07 |
| Normal-vs-Asian |
3.320500E-03 |
| Caucasian-vs-AfricanAmerican |
9.625400E-01 |
| Caucasian-vs-Asian |
1.828380E-01 |
| AfricanAmerican-vs-Asian |
2.144600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.81266113230549E-12 |
| Normal-vs-Female |
1.09109999923973E-08 |
| Male-vs-Female |
9.178800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.973200E-04 |
| Normal-vs-Extreme_Weight |
6.76369960039835E-10 |
| Normal-vs-Obese |
5.05889999891096E-08 |
| Normal-vs-Extreme_Obese |
2.152900E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.558200E-01 |
| Normal_Weight-vs-Obese |
3.407000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.749200E-01 |
| Extreme_Weight-vs-Obese |
3.621400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.505400E-01 |
| Obese-vs-Extreme_Obese |
5.787600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.226300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.2099210522365E-12 |
| Normal-vs-Age(61-80Yrs) |
5.70509994801682E-09 |
| Normal-vs-Age(81-100Yrs) |
1.100500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.572600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.816040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.160580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.680800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.169000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.507200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.74442707343314E-12 |
| Normal-VS-Type2 PRCC |
9.52610000000131E-05 |
| Normal-VS-KIRP CIMP |
2.249000E-04 |
| Normal-VS-Unclassified PRCC |
6.784800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.703000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.950300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.211000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.175190E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.591590E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.975400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.002700E-03 |
| Normal-vs-N1 |
5.981100E-04 |
| Normal-vs-N2 |
7.829600E-02 |
| N0-vs-N1 |
1.209220E-01 |
| N0-vs-N2 |
2.000800E-01 |
| N1-vs-N2 |
1.622380E-02 |
|
|
